Close Menu

Enterome

The new company will develop microbiome diagnostics for multiple indications including inflammatory bowel disease and liver disorders.

The companies will discover and develop microbiome-derived biomarkers, drug targets, and bioactive molecules for cancer.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.